1.
Saudi Medical Journal. 2009; 30 (9): 1228-1230
in English
| IMEMR
| ID: emr-102317
ABSTRACT
UndifFerentiated spondyloarthropathies [USPA] can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor [TNF] -alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment